Our two Cell Therapy Platforms are now being differentiated and categorised as one "internal" and one "external".
Shellbell, where have you seen that one of the Cell Therapy Platforms is internal and the other external?
Was it the reference in Slide 4 of the presentation?
If so, perhaps ambiguous, but my reading was that both platforms can benefit both PTX’s internal programs, as well as external programs.
Ann: PTX Presentation, page-25
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
